home / stock / phguf / phguf quote
Last: | $0.95386 |
---|---|
Change Percent: | -5.38% |
Open: | $0.95386 |
Close: | $0.95386 |
High: | $0.95386 |
Low: | $0.95386 |
Volume: | 580 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.95386 | $0.95386 | $0.95386 | $0.95386 | $0.95386 | 580 | 04-26-2024 |
$0.9052 | $0.9052 | $0.9052 | $0.9052 | $0.9052 | 1,000 | 04-25-2024 |
$0.95 | $0.95 | $0.95 | $0.95 | $0.95 | 300 | 04-17-2024 |
$1.065 | $1.065 | $1.065 | $1.065 | $1.065 | 2,000 | 04-10-2024 |
$1.2 | $1.18 | $1.2 | $1.2 | $1.18 | 400 | 03-11-2024 |
$1.145 | $1.152 | $1.145 | $1.152 | $1.145 | 1,600 | 03-07-2024 |
$1.11 | $1.125 | $1.11 | $1.125 | $1.11 | 13,000 | 03-06-2024 |
$1.13 | $1.13 | $1.13 | $1.13 | $1.13 | 600 | 02-29-2024 |
$1.17 | $1.17 | $1.17 | $1.17 | $1.17 | 2,192 | 02-12-2024 |
$1.29 | $1.29 | $1.29 | $1.29 | $1.29 | 500 | 01-30-2024 |
$1.175 | $0 | $1.175 | $0 | $0 | 50 | 01-24-2024 |
$1.175 | $1.175 | $1.175 | $1.175 | $1.175 | 1,000 | 12-14-2023 |
$1.15 | $1.15 | $1.15 | $1.15 | $1.15 | 2,000 | 12-08-2023 |
$1.14 | $1.14 | $1.14 | $1.14 | $1.14 | 1,500 | 12-04-2023 |
$1.14 | $0 | $1.14 | $0 | $0 | 10 | 11-28-2023 |
$1.14 | $0 | $1.14 | $0 | $0 | 170,000 | 10-10-2023 |
$1.14 | $1.14 | $1.14 | $1.14 | $1.14 | 2,000 | 10-09-2023 |
$1.16 | $1.16 | $1.16 | $1.16 | $1.16 | 7,138 | 10-05-2023 |
$1.3 | $1.3 | $1.3 | $1.3 | $1.3 | 100 | 09-28-2023 |
$1.4 | $1.35 | $1.4 | $1.4 | $1.35 | 400 | 09-21-2023 |
News, Short Squeeze, Breakout and More Instantly...
Pharming Group Nv Ord Company Name:
PHGUF Stock Symbol:
OTCMKTS Market:
Recognition given for achievement in commercializing Joenja® (leniolisib), a first-in-class medication brought to market 10 years after disease state, APDS, was first characterized Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming” or “...
This multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency Leiden, the Netherlands, April 8, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHAR...
Leiden, The Netherlands, April 3, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of April: 23rd Annual Needham Virtual Healthc...